Pharmaceuticals, Biotechnology and Life Sciences
Alexion, AstraZeneca’s Rare Disease group, has entered into a settlement agreement with Chugai Pharmaceutical Co., Ltd. (Chugai), resolving all patent disputes between the two companies related to Ultomiris (ravulizumab).
Vivoryon Therapeutics a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group have announced that…
Sobi has announce that the Center for Drug Evaluation (CDE) has recommended approval of Gamifant to the National Medical Products…
– Partnership leverages Theramex’s leading women’s health capabilities and commercial infrastructure to support the commercialization and market introduction of linzagolix…
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.–(BUSINESS WIRE)–#CD39–Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company dedicated to discovering and…
BEIJING & SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies…
Phase 1/2 clinical study in patients with advanced solid tumor expected to start in 2Q2022 SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co.…
MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in…
Sandoz, a Novartis division, has acquired rights to three established brands (Zinnat, Zinacef and Fortum) in more than 100 markets,…
Japan has suspended more than 1.5 milion doses of Moderna vaccine after getting contamination reports